Drug Shortage Report for DEPO-TESTOSTERONE INJ 100MG/ML
Report ID | 130899 |
Drug Identification Number | 00030783 |
Brand name | DEPO-TESTOSTERONE INJ 100MG/ML |
Common or Proper name | DEPO-TESTOSTERONE |
Company Name | PFIZER CANADA ULC |
Market Status | MARKETED |
Active Ingredient(s) | TESTOSTERONE CYPIONATE |
Strength(s) | 100MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAMUSCULAR INTRAMUSCULAR |
Packaging size | 10mL vial |
ATC code | G03BA |
ATC description | ANDROGENS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2021-01-08 |
Estimated end date | |
Actual end date | 2021-02-05 |
Shortage status | Resolved |
Updated date | 2021-02-06 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2021-02-06 | English | Compare |
v7 | 2021-02-05 | French | Compare |
v6 | 2021-02-05 | English | Compare |
v5 | 2021-01-15 | French | Compare |
v4 | 2021-01-15 | English | Compare |
v3 | 2021-01-09 | English | Compare |
v2 | 2021-01-05 | French | Compare |
v1 | 2021-01-05 | English | Compare |
Showing 1 to 8 of 8